Neuren Pharmaceuticals | NEU - Net Income


Neuren Pharmaceuticals reported AUD15.4M in Net Income for its fiscal semester ending in December of 2025.





Net Income Change Date
Akebia Therapeutics USD -12.24M 12.78M Dec/2025
Alaunos Therapeutics USD -1.01M 153K Mar/2026
Avita Medical AUD -11.62M 1.7M Dec/2025
Clinuvel Pharmaceuticals AUD 10.44M 11.65M Dec/2025
Dianthus Therapeutics USD -40.83M 23.6M Mar/2026
Genetic Signatures AUD -6.36M 1.46M Dec/2025
Ionis Pharmaceuticals USD -114.65M 21.65M Jun/2026
Medical Developments International AUD -226K 121K Dec/2025
Neuren Pharmaceuticals AUD 15.4M 7.88M Dec/2025
Organon & Co USD 108M 38M Jun/2026
Paradigm Biopharmaceuticals AUD -23.24M 16.82M Dec/2025
PYC Therapeutics AUD -22.83M 10.46M Dec/2025
Starpharma Holdings AUD 1.37M 3.67M Dec/2025
Tectonic Therapeutic USD -25.24M 6.02M Mar/2026
Telix Pharmaceuticals AUD 38.33M 43.16M Jun/2026
Viatris USD -118.8M 295.2M Jun/2026
Xeris Pharmaceuticals USD 2.23M 8.85M Mar/2026